JGO Weekly Summary (November 19, 2024)

JGO Weekly Summary (November 19, 2024)

This episode explores a study led by Dr. Shuai Huang from Beijing Hospital, examining the efficacy and safety of combining anlotinib, a multi-target tyrosine kinase inhibitor, with oral etoposide for treating platinum-resistant ovarian cancer. In a retrospective analysis of 22 patients, the combination therapy achieved a partial response rate of 45% and a disease control rate of 85%, with a median progression-free survival of 8.7 months. While all patients experienced adverse events, severe toxicities were manageable in most cases, though two patients discontinued treatment. The study highlights the potential of this oral regimen as a promising outpatient option, though further randomized trials are needed to validate its findings. Tune in to learn more about this innovative approach.


Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer (https://doi.org/10.3802/jgo.2024.35.e100)

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

JGO Weekly Summary (July 6, 2025)

JGO Weekly Summary (July 6, 2025)

This episode summarizes a cross-sectional study from Central China on HPV genotype distribution and infection risk factors. Ye Chen and colleagues found that HPV52, 16, and 58 were most common, with i...

6 Heinä 20254min

JGO Weekly Summary (May 11, 2025)

JGO Weekly Summary (May 11, 2025)

In this episode of the JGO Podcast, we explore a recent study from Peking Union Medical College Hospital examining the role of adjuvant surgery in patients with high-risk chemorefractory or relapsed g...

11 Touko 20254min

JGO Weekly Summary (April 29, 2025)

JGO Weekly Summary (April 29, 2025)

This episode features an in-depth discussion of the Asian cohort analysis from the AtTEnd/ENGOT-EN7 phase III trial, which evaluated atezolizumab in combination with carboplatin and paclitaxel for adv...

1 Touko 20255min

JGO Weekly Summary (April 22, 2025)

JGO Weekly Summary (April 22, 2025)

In this episode, we review findings from the Japan subset of the DUO-E phase III trial, led by Shin Nishio and colleagues, which evaluated durvalumab with or without olaparib following chemotherapy in...

22 Huhti 20254min

JGO Weekly Summary (April 10, 2025)

JGO Weekly Summary (April 10, 2025)

In this episode, we discuss the final analysis of the KEYNOTE-826 subgroup study led by Dr. Yong-Man Kim, evaluating pembrolizumab plus chemotherapy with or without bevacizumab in East Asian patients ...

10 Huhti 20255min

JGO Weekly Summary (March 25, 2025)

JGO Weekly Summary (March 25, 2025)

In this episode of the Journal of Gynecologic Oncology podcast, we review a recent meta-analysis by Tianyu Zhang and colleagues titled "Role of Adjuvant Chemotherapy in Stage IC Ovarian Granulosa Cell...

26 Maalis 20255min

JGO Weekly Summary (March 18, 2025)

JGO Weekly Summary (March 18, 2025)

In this episode of the Journal of Gynecologic Oncology podcast, we discuss a study by Baldwin and colleagues titled Evaluation of the Role of Liver Metastasectomy in the Treatment of Stage IV Endometr...

19 Maalis 20254min

JGO Weekly Summary (March 11, 2025)

JGO Weekly Summary (March 11, 2025)

This episode explores a recent study on the increased risk of cardiovascular disease among adolescent and young adult survivors of cervical cancer. Using data from the Korean National Health Insurance...

11 Maalis 20255min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
rss-pitaisko-erota
meditaatiot-suomeksi
psykopodiaa-podcast
terapiassa
voi-hyvin-meditaatiot-2
rss-uplevel-by-sonja-hannus
katilon-kahvitunti
rss-kuumilla-aalloilla
rss-pt-paahtio
rss-vapaudu-voimaasi
junnut-pelissa
fitnessvastaanotto
selviytyjat-tarinoita-elamasta
rss-sanelunpurku-podcast
docemilia
paritellen
rss-seksicast